// App-Quantinova.ai

AP177 : SERUM SOLUBLE IL‐2 RECEPTOR IS A POSSIBLE PROGNOSTIC BIOMARKER IN IDIOPATHIC INTERSTITIAL PNEUMONIA

Researchers

Presenter

  • YOSHINORI TANINO

Principal Investigators

  • YUKI SATO

  • TAKEFUMI NIKAIDO

  • RYUICHI TOGAWA

  • YASUHITO SUZUKI

  • MANABU UEMATSU

  • ATSURO FUKUHARA

  • SUGURU SATO

  • JUNPEI SAITO

  • YOKO SHIBATA

Medical Centers

  • Department of Pulumonary Medicine, Fukushima Medical University, Fukushima, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic interstitial pneumonias

  • Idiopathic pulmonary fibrosis

  • Pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved